Results 1 to 10 of about 336,084 (346)
Metastatic basal cell carcinoma with evidence of intravascular invasion: A case report [PDF]
SAGE Open Medical Case Reports, 2020 Although basal cell carcinoma is the most common malignancy in humans, intravascular basal cell carcinoma is rarely reported in the literature.
Lindsey West +3 more
doaj +3 more sources
Metastatic basal cell carcinoma
Journal of Radiation and Cancer Research, 2021 Basal cell carcinoma (BCC) is the most frequent, slow–growing, and potentially locally aggressive neoplasm of skin that rarely metastasizes. Incidence of BCC is high, but metastatic BCC is extremely rare.
Isha Shah, Aastha Shah, U Suryanarayan
doaj +4 more sources
Metastatic Basal Cell Carcinoma. [PDF]
Am J Clin Pathol, 2019 OBJECTIVES Diagnosis of metastatic basal cell carcinoma (BCC) remains challenging, in part due to its rarity. With the advent of molecularly targeted therapies, recognition of this entity is more important than ever.
Laga AC +4 more
europepmc +5 more sources
Metastatic basal cell carcinoma: case report and review of the literature
Indian Journal of Dermatology, 2020 Basal cell carcinoma (BCC) is the most commonly occurring carcinoma among humans. However, despite their overall frequency, cases of BCC featuring metastases are extremely rare.
Jose-Francisco Millan-Cayetano +6 more
doaj +3 more sources
Metastatic Basal Cell Carcinoma Accompanying Gorlin Syndrome [PDF]
Case Reports in Oncological Medicine, 2014 Gorlin-Goltz syndrome or basal cell nevus syndrome is an autosomal dominant syndrome characterized by skeletal anomalies, numerous cysts observed in the jaw, and multiple basal cell carcinoma of the skin, which may be accompanied by falx cerebri ...
Yeliz Bilir +5 more
doaj +3 more sources
Metastatic basal cell carcinoma to the lungs: Case report and review of literature [PDF]
Indian Dermatology Online Journal, 2014 Basal cell carcinoma is the most common form of skin cancer and it rarely metastasizes. The prevalence of metastatic basal cell carcinoma (MBCC) varies between 0.0028% and 0.55% of all cases. Over 250 MBCC have been reported in the literature. We present
Henry Benson Nongrum +3 more
doaj +3 more sources
Metastatic Basal Cell Carcinoma: A Rare Manifestation of a Common Disease [PDF]
Case Reports in Medicine, 2017 Introduction. Basal cell carcinoma (BCC) is considered the most common malignancy in Caucasians. It constituted about 80% of all nonmelanoma skin tumors and, despite its high prevalence, is an extremely rare occurrence of metastases, with incidence rates
Paola Piva de Freitas +4 more
doaj +3 more sources
Metastatic basal cell carcinoma to the bone: a case of bone metastatis in unfrequent sites [PDF]
Dermatology Reports, 2022 Basal cell carcinoma (BCC) is the most common malignant tumor of the skin. Despite the indolent nature, metastatic BCC can occur, albeit rarely. Metastasis to the bone are very rare.
Olga Nigro +8 more
doaj +2 more sources
Metastatic Basal Cell Carcinoma: A Biological Continuum of Basal Cell Carcinoma? [PDF]
Case Reports in Dermatological Medicine, 2012 Basal cell carcinoma (BCC) accounts for 80% of all nonmelanoma skin cancers. Its metastasis is extremely rare, ranging between 0.0028 and 0.55 of all BCC cases. The usual metastasis to lymph nodes, lungs, bones, or skin is from the primary tumor situated
Karaninder S. Mehta +9 more
doaj +4 more sources
Metastatic basal cell carcinoma with atypical pattern of spread [PDF]
Radiology Case Reports, 2020 Basal cell carcinoma is the most common malignancy in the United States. However, metastasis of basal cell carcinoma is exceedingly rare, with incidence estimates of 0.0028–0.055%.
Matthew Gellatly, BA +3 more
doaj +2 more sources